Cargando…
Empirical antibiotic treatment for community-acquired pneumonia and accuracy for Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department
BACKGROUND: Many factors determine empirical antibiotic treatment of community-acquired pneumonia (CAP). We aimed to describe the empirical antibiotic treatment CAP patients with an acute hospital visit and to determine if the current treatment algorithm provided specific and sufficient coverage aga...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481610/ https://www.ncbi.nlm.nih.gov/pubmed/37670282 http://dx.doi.org/10.1186/s12879-023-08565-6 |
_version_ | 1785102016431783936 |
---|---|
author | Lorentzen, Morten Hjarnø Rosenvinge, Flemming Schønning Lassen, Annmarie Touborg Graumann, Ole Laursen, Christian B. Mogensen, Christian Backer Skjøt-Arkil, Helene |
author_facet | Lorentzen, Morten Hjarnø Rosenvinge, Flemming Schønning Lassen, Annmarie Touborg Graumann, Ole Laursen, Christian B. Mogensen, Christian Backer Skjøt-Arkil, Helene |
author_sort | Lorentzen, Morten Hjarnø |
collection | PubMed |
description | BACKGROUND: Many factors determine empirical antibiotic treatment of community-acquired pneumonia (CAP). We aimed to describe the empirical antibiotic treatment CAP patients with an acute hospital visit and to determine if the current treatment algorithm provided specific and sufficient coverage against Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae (LMC). METHODS: A descriptive cross-sectional, multicenter study of all adults with an acute hospital visit in the Region of Southern Denmark between January 2016 and March 2018 was performed. Using medical records, we retrospectively identified the empirical antibiotic treatment and the microbiological etiology for CAP patients. CAP patients who were prescribed antibiotics within 24 h of admission and with an identified bacterial pathogen were included. The prescribed empirical antibiotic treatment and its ability to provide specific and sufficient coverage against LMC pneumonia were determined. RESULTS: Of the 19,133 patients diagnosed with CAP, 1590 (8.3%) patients were included in this study. Piperacillin-tazobactam and Beta-lactamase sensitive penicillins were the most commonly prescribed empirical treatments, 515 (32%) and 388 (24%), respectively. Our analysis showed that 42 (37%, 95% CI: 28–47%) of 113 patients with LMC pneumonia were prescribed antibiotics with LMC coverage, and 42 (12%, 95% CI: 8–15%) of 364 patients prescribed antibiotics with LMC coverage had LMC pneumonia. CONCLUSION: Piperacillin-tazobactam, a broad-spectrum antibiotic recommended for uncertain infectious focus, was the most frequent CAP treatment and prescribed to every third patient. In addition, the current empirical antibiotic treatment accuracy was low for LMC pneumonia. Therefore, future research should focus on faster diagnostic tools for identifying the infection focus and precise microbiological testing. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08565-6. |
format | Online Article Text |
id | pubmed-10481610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104816102023-09-07 Empirical antibiotic treatment for community-acquired pneumonia and accuracy for Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department Lorentzen, Morten Hjarnø Rosenvinge, Flemming Schønning Lassen, Annmarie Touborg Graumann, Ole Laursen, Christian B. Mogensen, Christian Backer Skjøt-Arkil, Helene BMC Infect Dis Research BACKGROUND: Many factors determine empirical antibiotic treatment of community-acquired pneumonia (CAP). We aimed to describe the empirical antibiotic treatment CAP patients with an acute hospital visit and to determine if the current treatment algorithm provided specific and sufficient coverage against Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae (LMC). METHODS: A descriptive cross-sectional, multicenter study of all adults with an acute hospital visit in the Region of Southern Denmark between January 2016 and March 2018 was performed. Using medical records, we retrospectively identified the empirical antibiotic treatment and the microbiological etiology for CAP patients. CAP patients who were prescribed antibiotics within 24 h of admission and with an identified bacterial pathogen were included. The prescribed empirical antibiotic treatment and its ability to provide specific and sufficient coverage against LMC pneumonia were determined. RESULTS: Of the 19,133 patients diagnosed with CAP, 1590 (8.3%) patients were included in this study. Piperacillin-tazobactam and Beta-lactamase sensitive penicillins were the most commonly prescribed empirical treatments, 515 (32%) and 388 (24%), respectively. Our analysis showed that 42 (37%, 95% CI: 28–47%) of 113 patients with LMC pneumonia were prescribed antibiotics with LMC coverage, and 42 (12%, 95% CI: 8–15%) of 364 patients prescribed antibiotics with LMC coverage had LMC pneumonia. CONCLUSION: Piperacillin-tazobactam, a broad-spectrum antibiotic recommended for uncertain infectious focus, was the most frequent CAP treatment and prescribed to every third patient. In addition, the current empirical antibiotic treatment accuracy was low for LMC pneumonia. Therefore, future research should focus on faster diagnostic tools for identifying the infection focus and precise microbiological testing. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08565-6. BioMed Central 2023-09-05 /pmc/articles/PMC10481610/ /pubmed/37670282 http://dx.doi.org/10.1186/s12879-023-08565-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lorentzen, Morten Hjarnø Rosenvinge, Flemming Schønning Lassen, Annmarie Touborg Graumann, Ole Laursen, Christian B. Mogensen, Christian Backer Skjøt-Arkil, Helene Empirical antibiotic treatment for community-acquired pneumonia and accuracy for Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department |
title | Empirical antibiotic treatment for community-acquired pneumonia and accuracy for Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department |
title_full | Empirical antibiotic treatment for community-acquired pneumonia and accuracy for Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department |
title_fullStr | Empirical antibiotic treatment for community-acquired pneumonia and accuracy for Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department |
title_full_unstemmed | Empirical antibiotic treatment for community-acquired pneumonia and accuracy for Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department |
title_short | Empirical antibiotic treatment for community-acquired pneumonia and accuracy for Legionella pneumophila, Mycoplasma pneumoniae, and Clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department |
title_sort | empirical antibiotic treatment for community-acquired pneumonia and accuracy for legionella pneumophila, mycoplasma pneumoniae, and clamydophila pneumoniae: a descriptive cross-sectional study of adult patients in the emergency department |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481610/ https://www.ncbi.nlm.nih.gov/pubmed/37670282 http://dx.doi.org/10.1186/s12879-023-08565-6 |
work_keys_str_mv | AT lorentzenmortenhjarnø empiricalantibiotictreatmentforcommunityacquiredpneumoniaandaccuracyforlegionellapneumophilamycoplasmapneumoniaeandclamydophilapneumoniaeadescriptivecrosssectionalstudyofadultpatientsintheemergencydepartment AT rosenvingeflemmingschønning empiricalantibiotictreatmentforcommunityacquiredpneumoniaandaccuracyforlegionellapneumophilamycoplasmapneumoniaeandclamydophilapneumoniaeadescriptivecrosssectionalstudyofadultpatientsintheemergencydepartment AT lassenannmarietouborg empiricalantibiotictreatmentforcommunityacquiredpneumoniaandaccuracyforlegionellapneumophilamycoplasmapneumoniaeandclamydophilapneumoniaeadescriptivecrosssectionalstudyofadultpatientsintheemergencydepartment AT graumannole empiricalantibiotictreatmentforcommunityacquiredpneumoniaandaccuracyforlegionellapneumophilamycoplasmapneumoniaeandclamydophilapneumoniaeadescriptivecrosssectionalstudyofadultpatientsintheemergencydepartment AT laursenchristianb empiricalantibiotictreatmentforcommunityacquiredpneumoniaandaccuracyforlegionellapneumophilamycoplasmapneumoniaeandclamydophilapneumoniaeadescriptivecrosssectionalstudyofadultpatientsintheemergencydepartment AT mogensenchristianbacker empiricalantibiotictreatmentforcommunityacquiredpneumoniaandaccuracyforlegionellapneumophilamycoplasmapneumoniaeandclamydophilapneumoniaeadescriptivecrosssectionalstudyofadultpatientsintheemergencydepartment AT skjøtarkilhelene empiricalantibiotictreatmentforcommunityacquiredpneumoniaandaccuracyforlegionellapneumophilamycoplasmapneumoniaeandclamydophilapneumoniaeadescriptivecrosssectionalstudyofadultpatientsintheemergencydepartment |